Bladder Cancer Mortality in Men Lower When treated with Prostate Enlargement medication Dutasteride or Finasteride

29.03.2018

Use of 5-alpha-reductase inhibitors (5-ARIs, Dutasteride or Finasteride) is associated with a lower risk of dying from bladder cancer among men newly diagnosed with the malignancy, researchers reported at the 33rdEuropean Association of Urology Congress in Copenhagen, Denmark.

In a study of 10,720 men newly diagnosed with bladder cancer during 1997 to 2012, the researchers found that 5-ARI use before diagnosis and after diagnosis was associated with a significant 15% and 22% decreased the risk of bladder cancer-specific death, respectively, compared with non-use.

The study supports the role of androgens and benefits of 5-alpha-reductase inhibition in the progression of bladder cancer, the investigators concluded.

Reference

Mäkelä VJ, Kotsar A, Tammela TL, Murtola TJ. Bladder cancer survival in men using 5-alpha-reductase inhibitors. Data presented at the 33rd European Association of Urology Congress in Copenhagen, Denmark.

Send me a message if you have any question or make an appointment (toll-free: 800444444 or +971 4 520 0500)

Emirates Hospital, Jumeirah Beach Road, opposite Jumeirah Park (below the Dubai Canal Bridge Take the U-turn under the bridge to reach the entrance) - Dubai